MODULATORS OF THE RETINOID-RELATED ORPHAN RECEPTOR GAMMA (ROR-GAMMA) FOR USE IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES
申请人:Glaxo Group Limited
公开号:EP3219711A1
公开(公告)日:2017-09-20
The present invention relates to retinoid-related orphan receptor gamma (RORγ) modulators of formula (I)v for use in the treatment of autoimmune or inflammatory diseases.